Eculizumab (Soliris) in Covid-19 Infected Patients
NCT04288713
·
clinicaltrials.gov ↗
AVAILABLE
Status
OTHER
Sponsor class
Conditions
Coronavirus
Interventions
DRUG:
Eculizumab
Sponsor
Hudson Medical